Koligo therapeutics
Louisville
About Koligo therapeutics
Koligo Therapeutics’ mission is to develop, manufacture, and commercialize transformative cell therapies for the treatment of pancreatic diseases.Koligo is dedicated to supporting their mission while respecting their values.Their employees agree in writing to certain professional standards to codify our mutual understanding of Koligo’s ethics and conduct .
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $3.6M
- Funding stage: M&A
- Last round: Private Equity (Oct 2020)
- Website: kyslecel.com
- Phone: 40202 1-502-242-5890
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/koligo-therapeutics-38623 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.